日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Inhalation delivery dramatically improves the efficacy of topotecan for the treatment of local and distant lung cancer

吸入给药可显著提高拓扑替康治疗局部和远处肺癌的疗效。

Kuehl, Philip J; Yingling, Christin M; Dubose, Devon; Burke, Michael; Revelli, David A; Chen, Wenshu; Dye, Wendy W; Belinsky, Steven A; Tessema, Mathewos

5-Azacytidine inhaled dry powder formulation profoundly improves pharmacokinetics and efficacy for lung cancer therapy through genome reprogramming.

5-氮胞苷吸入干粉制剂通过基因组重编程显著改善肺癌治疗的药代动力学和疗效

Kuehl Philip J, Tellez Carmen S, Grimes Marcie J, March Thomas H, Tessema Mathewos, Revelli David A, Mallis Larry M, Dye Wendy W, Sniegowski Tyler, Badenoch Aaron, Burke Michael, Dubose Devon, Vodak David T, Picchi Maria A, Belinsky Steven A

Inhalation delivery of topotecan is superior to intravenous exposure for suppressing lung cancer in a preclinical model

在临床前模型中,吸入给药拓扑替康在抑制肺癌方面优于静脉给药。

Kuehl, Philip J; Grimes, Marcie J; Dubose, Devon; Burke, Michael; Revelli, David A; Gigliotti, Andrew P; Belinsky, Steven A; Tessema, Mathewos